NYSE: BMYBristol Myers Squibb Co Stock Ownership - Who owns Bristol Myers Squibb Co?
Insider buying vs selling
Have Bristol Myers Squibb Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Karin Shanahan | EVP Glob. Prod. Dev. Supply | 2024-04-01 | 1,196 | $52.99 | $63.38kSell |
| Robert M. Plenge | EVP Chief Research Officer | 2024-03-10 | 1,436 | $53.79 | $77.24kSell |
| Cari Gallman | EVP Corporate Affairs | 2024-03-10 | 97 | $53.79 | $5.22kSell |
| Adam Lenkowsky | EVP Chief Commercial Officer | 2024-03-10 | 3,235 | $53.79 | $174.01kSell |
| Adam Lenkowsky | EVP Chief Commercial Officer | 2024-03-10 | 570 | $53.79 | $30.66kSell |
| Adam Lenkowsky | EVP Chief Commercial Officer | 2024-03-10 | 518 | $53.79 | $27.86kSell |
| Samit Hirawat | EVPChief Med.Offr.Drug Dev. | 2024-03-10 | 9,774 | $53.79 | $525.74kSell |
| Samit Hirawat | EVPChief Med.Offr.Drug Dev. | 2024-03-10 | 2,068 | $53.79 | $111.24kSell |
| Samit Hirawat | EVPChief Med.Offr.Drug Dev. | 2024-03-10 | 1,807 | $53.79 | $97.20kSell |
| Robert M. Plenge | EVP Chief Research Officer | 2024-03-10 | 283 | $53.79 | $15.22kSell |
BMY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BMY insiders and whales buy or sell their stock.
BMY Shareholders
What type of owners hold Bristol Myers Squibb Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.18% | 186,067,109 | $8.19B | Institution |
| Blackrock Inc | 8.02% | 162,561,081 | $7.16B | Institution |
| State Street Corp | 4.52% | 91,571,110 | $4.03B | Institution |
| Jpmorgan Chase Co | 4.38% | 88,814,123 | $3.91B | Institution |
| Capital International Investors | 3.46% | 70,203,814 | $3.09B | Institution |
| Charles Schwab Investment Management Inc | 2.65% | 53,715,966 | $2.37B | Institution |
| Fmr LLC | 2.10% | 42,565,202 | $1.87B | Institution |
| Geode Capital Management LLC | 2.04% | 41,304,605 | $1.82B | Institution |
| Morgan Stanley | 1.44% | 29,269,610 | $1.29B | Institution |
| Primecap Management Co | 1.15% | 23,273,407 | $1.02B | Institution |
BMY vs General Drug Manufacturer Stocks
Bristol Myers Squibb Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.